- October 20, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Pavulon
Synonyms :
pancuronium
Class :
Neuromuscular Blockers, Nondepolarizing
ADVERTISEMENT
Brand Name :
Pavulon
Synonyms :
pancuronium
Class :
Neuromuscular Blockers, Nondepolarizing
Dosage forms & Strengths:
Injectable solution:
1 mg/ml
2 mg/ml
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may increase the neuromuscular effect of corticosteroids
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of Inhalational Anesthetics
neomycin/polymyxin B/gramicidin ophthalmic
may increase the neuromuscular-blocking effect of Polymyxin B
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the therapeutic effect
may increase the tachycardic effect
may increase the tachycardic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
vancomycin may enhance the effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agents
methyldopa/hydrochlorothiazide
may increase the neuromuscular blocking effect of thiazide and thiazide like diuretics
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the cholinergic effect of cholinergic agents
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular blocking effect of magnesium salts
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may diminish the serum concentration when combined with neuromuscular-blocking agents
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
